For research use only
| Cat No. | ABC-RC007Y |
| Product Type | Reporter Stable Cell Lines |
| Cell Type | Epithelial |
| Species | Mouse |
| Host Cell | KLN205 |
| Source Organ | Lung |
| Disease | Squamous Cell Carcinoma |
| Storage | Liquid Nitrogen |
KLN205/STAT5 Reporter (Luc) Stable Cell Line by AcceGen enables sensitive quantification of STAT5 pathway activation via luciferase for cancer research.
KLN205/STAT5 Reporter (Luc) Stable Cell Line is a bioluminescent reporter model derived from murine lung squamous carcinoma KLN205 cells, featuring stable integration of a luciferase (Luc) gene under the control of STAT5-responsive promoter elements. This engineered system enables sensitive, quantitative monitoring of STAT5 pathway activation via luciferase activity, while retaining the epithelial morphology and tumorigenic features of parental KLN205 cells. The luciferase reporter provides a robust readout of STAT5 dynamics in response to cytokines such as IL-2 and GM-CSF, or to pharmacological modulators, making it ideal for high-throughput screening and JAK-STAT mechanism studies. Applications include drug discovery targeting STAT5, analysis of cytokine signaling networks, and functional studies of tumor–microenvironment interactions. All cells are rigorously quality-controlled and confirmed negative for mycoplasma, fungi, yeast, and bacteria.
| Species | Mouse |
| Cat.No | ABC-RC007Y |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Disease | Squamous Cell Carcinoma |
| Biosafety Level | 2 |
| Storage | Liquid Nitrogen |
| Product Type | Reporter Stable Cell Lines |
| Host Cell | KLN205 |
| Gene Info | Luciferase (STAT5-responsive reporter) |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The KLN205/STAT5 Reporter (Luc) Stable Cell Line provides a sensitive bioluminescence-based platform for monitoring STAT5 signaling activity in real time. It enables quantitative evaluation of JAK-STAT pathway activation through luciferase expression, offering high sensitivity for drug screening and cytokine response analysis. The bioluminescent readout supports longitudinal, non-invasive monitoring of STAT5 activity in vitro and in vivo, making it particularly valuable for testing STAT5 inhibitors, mapping pathway crosstalk, and studying lung squamous carcinoma biology.